NEW YORK--(BUSINESS WIRE)--Jun 1, 2026--
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) and reminds investors of the June 1, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601532429/en/
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that the study design for the Company’s Phase 3 PROSERA study, particularly, controlling for the placebo response at the Latin American testing sites.
On February 23, 2026, Gossamer Bio, Inc. revealed adverse topline results from its Phase 3 PROSERA study, announcing that the trial failed to meet its primary endpoint of improving six-minute walk distance (“6MWD”) at Week 24. While the study reported a placebo-adjusted gain of +13.3 meters, the result did not achieve statistical significance under the prespecified alpha threshold of 0.025 (p=0.0320). The Company attributed the outcome, in part, to unexpectedly strong placebo performance among patients enrolled at Latin American sites, which it characterized as a heavily treated, lower-risk population.
Following this disclosure, investors and analysts reacted swiftly and negatively. On February 23, 2026, Gossamer’s common stock price plummeted from a closing price of $2.13 per share on February 20, 2026 to $0.42 per share, representing a decline of more than 80% in a single trading day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Gossamer’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Gossamer Bio class action, go to www.faruqilaw.com/GOSS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline
OMAHA, Neb. (AP) — Berkshire Hathaway's new CEO Greg Abel hinted that he may depart from Warren Buffett's longtime hands-off operating model at the conglomerate as he announced a $6.8 billion acquisition of homebuilder Taylor Morrison.
Abel suggested in the deal announcement he plans to consolidate Taylor Morrison with Berkshire's exisiting site-built homebuilding operations that are part of its Clayton Homes subsidiary. For six decades under Buffett, Berkshire promised to largely leave companies alone after it acquired them and allow the executives to keep running the day-to-day operations the same way.
“We are excited to welcome Taylor Morrison into Berkshire’s portfolio, reflecting our long-standing commitment to housing, exemplified by Clayton Homes and our other building products businesses. Over time, we expect to unify our site-built homebuilding operations into a combined platform enabling us to deliver the dream of homeownership to more Americans," Abel said in the announcement.
In addition to Clayton, which specializes in manufactured homes but also has a site-built unit, Berkshire also owns several other housing related businesses including Benjamin Moore paint and Shaw Floors.
It's not clear how much consolidating Abel might do among Berkshire's dozens of companies that include an assortment of major insurers, including Geico, major manufacturers such as Precision Castparts and a bunch of retail and service companies like NetJets, Dairy Queen and Helzberg Diamonds. But Abel is known as a much more active manager than Buffett ever was.
“Given Greg’s strength as an operator it will be interesting to see if he does consolidate these units to get some greater scale and efficiencies,” said CFRA Research analyst Cathy Seifert.
Abel has been overseeing all of Berkshire's non-insurance businesses since 2018, and he hasn't made any major changes in operations though he has encouraged subsidiares to cooperate more when it makes sense. Abel became CEO in January, but Buffett remains chairman and Berkshire's largest shareholder.
Berkshire shareholders will likely be excited just to see Abel making deals given that the Omaha-based compay is currently sitting on nearly $400 billion cash. This deal by itself isn't likely to make a meaningful impact on Berkshire's bottom line because the conglomerate is so big, but dealmaking and investing are the areas of Abel's resume that investors had the most questions about.
Buffett praised Abel in an interview with CNBC on Monday morning.
“Greg did that faster than I could have done it, smoother than I could have done it, and I never talked to the CEO. He has launched,” Buffett told CNBC.
Abel has led acquisitions before while leading Berkshire's massive utility division, but obviously Buffett would have signed off on those. Now Abel is making the decisions with advice from Buffett and the rest of the board.
“I think investors will cheer Greg’s foray into M&A as CEO. The purchase price seems rich given the current interest rate/macro environment,” Seifert said.
Berkshire agreed to pay Taylor Morrison investors $72.50 per share in the all-cash deal. That represents a 24% premium over the company's previous closing price of $58.50. Shares of the Scottsdale, Arizona-based homebuilder jumped up near that purchase price on Monday while Berkshire's shares slipped 1%.
But Raymond James analyst Buck Horne said in a research note that it's possible Berkshire could face some competition from private equity firms or other potential buyers who might be willing to pay more for Taylor Morrison before its shareholders can vote on whether to accept this offer.
“We would not be shocked if other players and/or private equity began to sharpen their pencils before the ink on this agreement is fully dry,” Horne said.
FILE - Berkshire Hathaway Vice Chairman Greg Abel poses for pictures with shareholders while touring the booths Berkshires companies set up, May 3, 2024, in Omaha, Neb. (AP Photo/Josh Funk, file)
FILE - Portraits of Berkshire Hathaway's Warren Buffett, left, and CEO Greg Abel sit in a semi truck at the Pilot display in the Berkshire Hathaway annual meeting on May 2, 2026, in Omaha, Neb. (AP Photo/Rebecca S. Gratz, file)
